調査レポート | • レポートコード：GIR-2104Z00956 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗がん剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗がん剤の種類別市場規模（細胞毒性薬（アルキル化剤、代謝拮抗剤）、標的薬（モノクローナル抗体・チロシンキナーゼ阻害剤）、ホルモン薬）、用途別市場規模（肺がん、乳がん、白血病、結腸直腸がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗がん剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：F. Hoffmann-La Roche Ltd、Eli Lilly and Company、CELGENE CORPORATION、Novartis AG、Pfizer Inc、Amgen Inc、Bayer AG、AstraZeneca、Takeda Pharmaceutical Company Limited、Merck & Co. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：細胞毒性薬（アルキル化剤、代謝拮抗剤）、標的薬（モノクローナル抗体・チロシンキナーゼ阻害剤）、ホルモン薬 ・用途別分析2016年-2026年：肺がん、乳がん、白血病、結腸直腸がん、その他 ・抗がん剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗がん剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗がん剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗がん剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗がん剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anticancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anticancer Drugs size is estimated to be xx million in 2020 from USD 86710 million in 2019, with a change of XX% between 2019 and 2020. The global Anticancer Drugs market size is expected to grow at a CAGR of 3.5% for the next five years.
Market segmentation
Anticancer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
Market segment by Application can be divided into
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
Other
The key market players for global Anticancer Drugs market are listed below:
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
CELGENE CORPORATION
Novartis AG
Pfizer Inc
Amgen Inc
Bayer AG
AstraZeneca
Takeda Pharmaceutical Company Limited
Merck & Co.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Anticancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anticancer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
1.2.3 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
1.2.4 Hormonal Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Anticancer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Leukemia
1.3.5 Colorectal Cancer
1.3.6 Other
1.4 Global Anticancer Drugs Market Size & Forecast
1.4.1 Global Anticancer Drugs Sales in Value (2016-2026))
1.4.2 Global Anticancer Drugs Sales in Volume (2016-2026)
1.4.3 Global Anticancer Drugs Price by Type (2016-2026) & (USD/Kg)
1.5 Global Anticancer Drugs Production Capacity Analysis
1.5.1 Global Anticancer Drugs Total Production Capacity (2016-2026)
1.5.2 Global Anticancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anticancer Drugs Market Drivers
1.6.2 Anticancer Drugs Market Restraints
1.6.3 Anticancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche Ltd
2.1.1 F. Hoffmann-La Roche Ltd Details
2.1.2 F. Hoffmann-La Roche Ltd Major Business
2.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Product and Services
2.1.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business
2.2.3 Eli Lilly and Company Anticancer Drugs Product and Services
2.2.4 Eli Lilly and Company Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 CELGENE CORPORATION
2.3.1 CELGENE CORPORATION Details
2.3.2 CELGENE CORPORATION Major Business
2.3.3 CELGENE CORPORATION Anticancer Drugs Product and Services
2.3.4 CELGENE CORPORATION Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Anticancer Drugs Product and Services
2.4.4 Novartis AG Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pfizer Inc
2.5.1 Pfizer Inc Details
2.5.2 Pfizer Inc Major Business
2.5.3 Pfizer Inc Anticancer Drugs Product and Services
2.5.4 Pfizer Inc Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Amgen Inc
2.6.1 Amgen Inc Details
2.6.2 Amgen Inc Major Business
2.6.3 Amgen Inc Anticancer Drugs Product and Services
2.6.4 Amgen Inc Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Bayer AG
2.7.1 Bayer AG Details
2.7.2 Bayer AG Major Business
2.7.3 Bayer AG Anticancer Drugs Product and Services
2.7.4 Bayer AG Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Anticancer Drugs Product and Services
2.8.4 AstraZeneca Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Takeda Pharmaceutical Company Limited
2.9.1 Takeda Pharmaceutical Company Limited Details
2.9.2 Takeda Pharmaceutical Company Limited Major Business
2.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Product and Services
2.9.4 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Merck & Co.
2.10.1 Merck & Co. Details
2.10.2 Merck & Co. Major Business
2.10.3 Merck & Co. Anticancer Drugs Product and Services
2.10.4 Merck & Co. Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anticancer Drugs Sales by Manufacturer
3.1 Global Anticancer Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anticancer Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anticancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anticancer Drugs Manufacturer Market Share
3.4.2 Top 6 Anticancer Drugs Manufacturer Market Share
3.5 Global Anticancer Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anticancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anticancer Drugs Market Size by Region
4.1.1 Global Anticancer Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Anticancer Drugs Revenue by Region (2016-2026)
4.2 North America Anticancer Drugs Revenue (2016-2026)
4.3 Europe Anticancer Drugs Revenue (2016-2026)
4.4 Asia-Pacific Anticancer Drugs Revenue (2016-2026)
4.5 South America Anticancer Drugs Revenue (2016-2026)
4.6 Middle East and Africa Anticancer Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anticancer Drugs Sales in Volume by Type (2016-2026)
5.2 Global Anticancer Drugs Revenue by Type (2016-2026)
5.3 Global Anticancer Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anticancer Drugs Sales in Volume by Application (2016-2026)
6.2 Global Anticancer Drugs Revenue by Application (2016-2026)
6.3 Global Anticancer Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anticancer Drugs Sales by Type (2016-2026)
7.2 North America Anticancer Drugs Sales by Application (2016-2026)
7.3 North America Anticancer Drugs Market Size by Country
7.3.1 North America Anticancer Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Anticancer Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anticancer Drugs Sales by Type (2016-2026)
8.2 Europe Anticancer Drugs Sales by Application (2016-2026)
8.3 Europe Anticancer Drugs Market Size by Country
8.3.1 Europe Anticancer Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Anticancer Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anticancer Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Anticancer Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Anticancer Drugs Market Size by Region
9.3.1 Asia-Pacific Anticancer Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anticancer Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anticancer Drugs Sales by Type (2016-2026)
10.2 South America Anticancer Drugs Sales by Application (2016-2026)
10.3 South America Anticancer Drugs Market Size by Country
10.3.1 South America Anticancer Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Anticancer Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anticancer Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Anticancer Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Anticancer Drugs Market Size by Country
11.3.1 Middle East & Africa Anticancer Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anticancer Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anticancer Drugs Typical Distributors
12.3 Anticancer Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anticancer Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anticancer Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 4. F. Hoffmann-La Roche Ltd Major Business
Table 5. F. Hoffmann-La Roche Ltd Anticancer Drugs Product and Services
Table 6. F. Hoffmann-La Roche Ltd Anticancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly and Company Major Business
Table 9. Eli Lilly and Company Anticancer Drugs Product and Services
Table 10. Eli Lilly and Company Anticancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CELGENE CORPORATION Basic Information, Manufacturing Base and Competitors
Table 12. CELGENE CORPORATION Major Business
Table 13. CELGENE CORPORATION Anticancer Drugs Product and Services
Table 14. CELGENE CORPORATION Anticancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 16. Novartis AG Major Business
Table 17. Novartis AG Anticancer Drugs Product and Services
Table 18. Novartis AG Anticancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Inc Major Business
Table 21. Pfizer Inc Anticancer Drugs Product and Services
Table 22. Pfizer Inc Anticancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 24. Amgen Inc Major Business
Table 25. Amgen Inc Anticancer Drugs Product and Services
Table 26. Amgen Inc Anticancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 28. Bayer AG Major Business
Table 29. Bayer AG Anticancer Drugs Product and Services
Table 30. Bayer AG Anticancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Major Business
Table 33. AstraZeneca Anticancer Drugs Product and Services
Table 34. AstraZeneca Anticancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 36. Takeda Pharmaceutical Company Limited Major Business
Table 37. Takeda Pharmaceutical Company Limited Anticancer Drugs Product and Services
Table 38. Takeda Pharmaceutical Company Limited Anticancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 40. Merck & Co. Major Business
Table 41. Merck & Co. Anticancer Drugs Product and Services
Table 42. Merck & Co. Anticancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Anticancer Drugs Sales by Manufacturer (2019-2021e) & (MT)
Table 44. Global Anticancer Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Anticancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Anticancer Drugs Production Capacity by Company, (MT): 2020 VS 2021
Table 47. Head Office and Anticancer Drugs Production Site of Key Manufacturer
Table 48. Global Anticancer Drugs Sales by Region (2016-2021e) & (MT)
Table 49. Global Anticancer Drugs Sales by Region (2021-2026) & (MT)
Table 50. Global Anticancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Anticancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Anticancer Drugs Sales by Type (2016-2021e) & (MT)
Table 53. Global Anticancer Drugs Sales by Type (2021-2026) & (MT)
Table 54. Global Anticancer Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Anticancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Anticancer Drugs Price by Type (2016-2021e) & (USD/Kg)
Table 57. Global Anticancer Drugs Price by Type (2021-2026) & (USD/Kg)
Table 58. Global Anticancer Drugs Sales by Application (2016-2021e) & (MT)
Table 59. Global Anticancer Drugs Sales by Application (2021-2026) & (MT)
Table 60. Global Anticancer Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Anticancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Anticancer Drugs Price by Application (2016-2021e) & (USD/Kg)
Table 63. Global Anticancer Drugs Price by Application (2021-2026) & (USD/Kg)
Table 64. North America Anticancer Drugs Sales by Country (2016-2021e) & (MT)
Table 65. North America Anticancer Drugs Sales by Country (2021-2026) & (MT)
Table 66. North America Anticancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Anticancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Anticancer Drugs Sales by Type (2016-2021e) & (MT)
Table 69. North America Anticancer Drugs Sales by Type (2021-2026) & (MT)
Table 70. North America Anticancer Drugs Sales by Application (2016-2021e) & (MT)
Table 71. North America Anticancer Drugs Sales by Application (2021-2026) & (MT)
Table 72. Europe Anticancer Drugs Sales by Country (2016-2021e) & (MT)
Table 73. Europe Anticancer Drugs Sales by Country (2021-2026) & (MT)
Table 74. Europe Anticancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Anticancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Anticancer Drugs Sales by Type (2016-2021e) & (MT)
Table 77. Europe Anticancer Drugs Sales by Type (2021-2026) & (MT)
Table 78. Europe Anticancer Drugs Sales by Application (2016-2021e) & (MT)
Table 79. Europe Anticancer Drugs Sales by Application (2021-2026) & (MT)
Table 80. Asia-Pacific Anticancer Drugs Sales by Region (2016-2021e) & (MT)
Table 81. Asia-Pacific Anticancer Drugs Sales by Region (2021-2026) & (MT)
Table 82. Asia-Pacific Anticancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Anticancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Anticancer Drugs Sales by Type (2016-2021e) & (MT)
Table 85. Asia-Pacific Anticancer Drugs Sales by Type (2021-2026) & (MT)
Table 86. Asia-Pacific Anticancer Drugs Sales by Application (2016-2021e) & (MT)
Table 87. Asia-Pacific Anticancer Drugs Sales by Application (2021-2026) & (MT)
Table 88. South America Anticancer Drugs Sales by Country (2016-2021e) & (MT)
Table 89. South America Anticancer Drugs Sales by Country (2021-2026) & (MT)
Table 90. South America Anticancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Anticancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Anticancer Drugs Sales by Type (2016-2021e) & (MT)
Table 93. South America Anticancer Drugs Sales by Type (2021-2026) & (MT)
Table 94. South America Anticancer Drugs Sales by Application (2016-2021e) & (MT)
Table 95. South America Anticancer Drugs Sales by Application (2021-2026) & (MT)
Table 96. Middle East & Africa Anticancer Drugs Sales by Country (2016-2021e) & (MT)
Table 97. Middle East & Africa Anticancer Drugs Sales by Country (2021-2026) & (MT)
Table 98. Middle East & Africa Anticancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Anticancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Anticancer Drugs Sales by Type (2016-2021e) & (MT)
Table 101. Middle East & Africa Anticancer Drugs Sales by Type (2021-2026) & (MT)
Table 102. Middle East & Africa Anticancer Drugs Sales by Application (2016-2021e) & (MT)
Table 103. Middle East & Africa Anticancer Drugs Sales by Application (2021-2026) & (MT)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Anticancer Drugs Typical Distributors
Table 107. Anticancer Drugs Typical Customers
List of Figures
Figure 1. Anticancer Drugs Picture
Figure 2. Global Anticancer Drugs Sales Market Share by Type in 2020
Figure 3. Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Figure 4. Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Figure 5. Hormonal Drugs
Figure 6. Global Anticancer Drugs Sales Market Share by Application in 2020
Figure 7. Lung Cancer
Figure 8. Breast Cancer
Figure 9. Leukemia
Figure 10. Colorectal Cancer
Figure 11. Other
Figure 12. Global Anticancer Drugs Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 13. Global Anticancer Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Anticancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Anticancer Drugs Sales (2016-2026) & (MT)
Figure 34. Global Anticancer Drugs Production Capacity (2016-2026) & (MT)
Figure 35. Global Anticancer Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Anticancer Drugs Market Drivers
Figure 37. Anticancer Drugs Market Restraints
Figure 38. Anticancer Drugs Market Trends
Figure 39. Global Anticancer Drugs Sales Market Share by Manufacturer in 2020
Figure 40. Global Anticancer Drugs Revenue Market Share by Manufacturer in 2020
Figure 41. Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Anticancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Anticancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Anticancer Drugs Sales Market Share by Region (2016-2026)
Figure 45. Global Anticancer Drugs Revenue Market Share by Region (2016-2026)
Figure 46. North America Anticancer Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Europe Anticancer Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Anticancer Drugs Revenue (2016-2026) & (USD Million)
Figure 49. South America Anticancer Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Anticancer Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Global Anticancer Drugs Sales Market Share by Type (2016-2026)
Figure 52. Global Anticancer Drugs Revenue Market Share by Type (2016-2026)
Figure 53. Global Anticancer Drugs Price by Type (2016-2026) & (USD/Kg)
Figure 54. Global Anticancer Drugs Sales Market Share by Application (2016-2026)
Figure 55. Global Anticancer Drugs Revenue Market Share by Application (2016-2026)
Figure 56. Global Anticancer Drugs Price by Application (2016-2026) & (USD/Kg)
Figure 57. North America Anticancer Drugs Sales Market Share by Country (2016-2026)
Figure 58. North America Anticancer Drugs Revenue Market Share by Country (2016-2026)
Figure 59. North America Anticancer Drugs Sales Market Share by Type (2016-2026)
Figure 60. North America Anticancer Drugs Sales Market Share by Application (2016-2026)
Figure 61. Europe Anticancer Drugs Sales Market Share by Country (2016-2026)
Figure 62. Europe Anticancer Drugs Revenue Market Share by Country (2016-2026)
Figure 63. Europe Anticancer Drugs Sales Market Share by Type (2016-2026)
Figure 64. Europe Anticancer Drugs Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Anticancer Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Anticancer Drugs Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Anticancer Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Anticancer Drugs Sales Market Share by Application (2016-2026)
Figure 69. South America Anticancer Drugs Sales Market Share by Country (2016-2026)
Figure 70. South America Anticancer Drugs Revenue Market Share by Country (2016-2026)
Figure 71. South America Anticancer Drugs Sales Market Share by Type (2016-2026)
Figure 72. South America Anticancer Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Anticancer Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Anticancer Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Anticancer Drugs Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Anticancer Drugs Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の抗がん剤市場規模・現状・予測（2021年-2027年） Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy. Anticancer drugs are agents that demonstrate activity against malignant disease. They include alkylating agents, antime…- 世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
- 世界の乳がん用ジェネリック医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Generic Drugs Market The global Breast Cancer Generic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の乳がん用ジェネリック医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Generic Drugs Market The global Breast Cancer Generic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界のチロシンヒドロキシラーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…